Kennedy Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.9M Sell
1,009,461
-51,862
-5% -$1.13M 0.52% 30
2025
Q1
$25.7M Buy
1,061,323
+43,657
+4% +$1.06M 0.61% 18
2024
Q4
$21.2M Sell
1,017,666
-23,750
-2% -$496K 0.47% 30
2024
Q3
$20.7M Sell
1,041,416
-234,888
-18% -$4.67M 0.46% 32
2024
Q2
$19.8M Buy
1,276,304
+214,600
+20% +$3.32M 0.42% 42
2024
Q1
$16.9M Buy
1,061,704
+533,802
+101% +$8.51M 0.35% 70
2023
Q4
$8.87M Sell
527,902
-108,464
-17% -$1.82M 0.19% 197
2023
Q3
$7.44M Buy
636,366
+333,562
+110% +$3.9M 0.18% 206
2023
Q2
$4.07M Buy
+302,804
New +$4.07M 0.09% 337
2019
Q2
Sell
-999,787
Closed -$5.1M 696
2019
Q1
$5.1M Buy
+999,787
New +$5.1M 0.12% 323
2018
Q4
Sell
-1,042,645
Closed -$3.94M 696
2018
Q3
$3.94M Sell
1,042,645
-11,226
-1% -$42.4K 0.07% 470
2018
Q2
$3.29M Buy
1,053,871
+237,300
+29% +$740K 0.06% 521
2018
Q1
$1.95M Sell
816,571
-74,603
-8% -$178K 0.04% 605
2017
Q4
$3.48M Sell
891,174
-9,444
-1% -$36.9K 0.06% 529
2017
Q3
$2.27M Sell
900,618
-17,820
-2% -$44.9K 0.04% 594
2017
Q2
$2.54M Buy
918,438
+687,938
+298% +$1.9M 0.05% 553
2017
Q1
$449K Sell
230,500
-2,671
-1% -$5.2K 0.01% 697
2016
Q4
$245K Sell
233,171
-10,065
-4% -$10.6K ﹤0.01% 703
2016
Q3
$265K Sell
243,236
-4,475
-2% -$4.88K 0.01% 696
2016
Q2
$176K Buy
247,711
+3,259
+1% +$2.32K ﹤0.01% 696
2016
Q1
$286K Sell
244,452
-3,765
-2% -$4.41K 0.01% 711
2015
Q4
$608K Sell
248,217
-854
-0.3% -$2.09K 0.01% 690
2015
Q3
$747K Buy
+249,071
New +$747K 0.02% 671